July 2021
Multiple research reports have been published in the last month on the global CRO market:
3. https://www.businesswire.com/news/home/20210616005393/en
How the COVID-19 pandemic has brought about explosive change in adoption of digital technologies, and its lasting effect on life sciences:
Contract research organizations were hit last year as the COVID-19 pandemic disrupted clinical trials, but they are now seeing a resurgence in demand as drugmakers and governments invest in newer treatments:
Scientists are on the hunt for a universal vaccine that will protect against not only SARS-CoV-2, but other members of its family that may emerge in the future. One candidate is already in a Phase 1 clinical trial:
Nearly 6,000 clinical trial results are currently missing from the European trial registry, despite transparency rules requiring countries to upload results within 12 months of trial completion:
Medical researchers are beginning to shift their focus away from COVID-19 — but the pandemic could continue to affect clinical trials focused on other diseases:
A new study suggests that significant variation in the amount of virus from person to person may be a contributing factor to inconsistent findings reported in clinical trials for antiviral COVID-19 drugs:
COVID-19 affects men and women differently. So why don’t clinical trials report gender data?
AstraZeneca’s proposed $39billion acquisition of Alexion Pharmaceuticals has cleared its European Commission review. It follows competition clearances in the United States, Japan and a number of other countries around the world, but regulatory clearance in the UK is pending:
Practical actions for consideration to increase diversity in clinical trials - by Dr Esther Mukuka, National Institute for Health Research (NIHR) Head of Equality, Diversity and Inclusion:
